Medicilon was honored again the "Top Ten Drug Innovation Service Institutions of the Year" of the Ph

Medicilon was honored again the "Top Ten Drug Innovation Service Institutions of the Year" of the Ph

A Story by Medicilon
"

Recently, the "3rd Pharmaceutical Innovation Award", a major award that has attracted the attention of pharmaceutical industry experts, academia, and the capital market, was released. Medicilon was h

"

Recently, the "3rd Pharmaceutical Innovation Award", a major award that has attracted the attention of pharmaceutical industry experts, academia, and the capital market, was released.  Medicilon was honored again the "Top Ten Drug Innovation Service Institutions of the Year".  It once again demonstrates the industry's high recognition of Medicilon's technical strength, service capabilities and development potential.

The "Pharmaceutical Innovation Award" is organized by the Securities Times, aiming to promote the improvement of drug innovation capabilities by selecting outstanding drug innovation projects, outstanding companies and outstanding figures in China.  The selection expert committee conducts selection based on the "Finance - Innovative Drug Index" database, drug evaluation and other related factors.  The event attracted more than 100 pharmaceutical companies, innovative drug R&D companies, and medical service companies to participate.

www.medicilon.com

© 2023 Medicilon


My Review

Would you like to review this Story?
Login | Register




Share This
Email
Facebook
Twitter
Request Read Request
Add to Library My Library
Subscribe Subscribe


Stats

31 Views
Added on June 13, 2023
Last Updated on June 13, 2023
Tags: drug innovation service

Author

Medicilon
Medicilon

Cambridge, MA



About
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services for pharmaceutical enterprises and scientific research institutions around the w.. more..

Writing